Literature DB >> 8752297

Protection against rotavirus infections by DNA vaccination.

J E Herrmann1, S C Chen, E F Fynan, J C Santoro, H B Greenberg, S Wang, H L Robinson.   

Abstract

DNA vaccines encoding for murine rotavirus proteins VP4, VP6, or VP7 were tested in adult BALB/c mice for their ability to induce immune responses and protect against rotavirus challenge. A gene gun was used to inoculate vaccines into the epidermis. Rotavirus-specific serum antibodies, as measured by ELISA, and virus-specific cytotoxic T lymphocyte responses were generated by each of the three vaccines, but virus-neutralizing antibodies were detected only in mice that were inoculated with DNA vaccines encoding for VP4 and VP7. Efficacy of the vaccines was determined by challenge with 100 ID50 of homotypic rotavirus. Each of the three vaccines was effective in protecting mice against infection after rotavirus challenge as determined by reduction (P < .001) in virus excretion in mice receiving the DNA vaccines. These results demonstrate that DNA vaccination has potential as a new approach for control of rotavirus infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8752297     DOI: 10.1093/infdis/174.supplement_1.s93

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  Serum IgG mediates mucosal immunity against rotavirus infection.

Authors:  Larry E Westerman; Harold M McClure; Baoming Jiang; Jeffrey W Almond; Roger I Glass
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

Review 2.  Genetic vaccines--a revolution in vaccinology?

Authors:  Z Q Xiang; S Pasquini; Z He; H Deng; Y Wang; M A Blaszczyk-Thurin; H C Ertl
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Immunization of the female genital tract with a DNA-based vaccine.

Authors:  J B Livingston; S Lu; H Robinson; D J Anderson
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

4.  Expression of human rotavirus chimeric fusion proteins from replicating but non disseminating adenovectors and elicitation of rotavirus-specific immune responses in mice.

Authors:  Aurélie Girard; Elodie Roques; Marie-Claude St-Louis; Bernard Massie; Denis Archambault
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

5.  Molecular epidemiology of human group A rotavirus infections in the United Kingdom between 1995 and 1998.

Authors:  M Iturriza-Gómara; J Green; D W Brown; M Ramsay; U Desselberger; J J Gray
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

Review 6.  Rotavirus infections: guidelines for treatment and prevention.

Authors:  U Desselberger
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

7.  Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.

Authors:  Ningguo Feng; Jeffrey A Lawton; Joana Gilbert; Nelly Kuklin; Phuoc Vo; B V Venkataram Prasad; Harry B Greenberg
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

8.  Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles.

Authors:  S C Chen; D H Jones; E F Fynan; G H Farrar; J C Clegg; H B Greenberg; J E Herrmann
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production.

Authors:  Yi-jing Li; Guang-peng Ma; Gui-wei Li; Xin-yuan Qiao; Jun-wei Ge; Li-jie Tang; Min Liu; Li-wei Liu
Journal:  J Biomed Biotechnol       Date:  2010-06-06

10.  Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.

Authors:  Suvi Lappalainen; Kirsi Tamminen; Timo Vesikari; Vesna Blazevic
Journal:  Hum Vaccin Immunother       Date:  2013-06-18       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.